NASDAQ
IRadimed Corporation (IRMD) has a free cash flow growth of 44.97% as of Friday, May 29, 2026. This represents a 72.74% decrease compared to its 12-month average of 164.99%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.